methyl N-(4,6-diamino-2-{1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate
| Title | Journal |
|---|---|
| Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure. | Handbook of experimental pharmacology 20170101 |
| The molecular targets of approved treatments for pulmonary arterial hypertension. | Thorax 20160101 |
| Riociguat for the treatment of pulmonary hypertension. | Expert review of respiratory medicine 20150101 |
| Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. | P & T : a peer-reviewed journal for formulary management 20141101 |
| Riociguat: first global approval. | Drugs 20131101 |
| Pathways in pulmonary arterial hypertension: the future is here. | European respiratory review : an official journal of the European Respiratory Society 20121201 |
| Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and design. | European journal of heart failure 20120801 |
| BAY 41-2272, a soluble guanylate cyclase agonist, activates human mononuclear phagocytes. | British journal of pharmacology 20120701 |
| Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications. | Critical care research and practice 20120101 |
| Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade. | PloS one 20120101 |
| The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats. | PloS one 20120101 |
| cGMP Signaling, Phosphodiesterases and Major Depressive Disorder. | Current neuropharmacology 20111201 |
| NOX1, 2, 4, 5: counting out oxidative stress. | British journal of pharmacology 20111001 |
| Riociguat (BAY 63-2521) and warfarin: a pharmacodynamic and pharmacokinetic interaction study. | Journal of clinical pharmacology 20110701 |
| New perspectives for the treatment of pulmonary hypertension. | British journal of pharmacology 20110501 |
| Riociguat for the treatment of pulmonary hypertension. | Expert opinion on investigational drugs 20110401 |
| Soluble guanylate cyclase modulators in heart failure. | Current heart failure reports 20110301 |
| Recent trends in pulmonary arterial hypertension. | Lung India : official organ of Indian Chest Society 20110101 |
| Therapeutic strategies in pulmonary hypertension. | Frontiers in pharmacology 20110101 |
| Soluble guanylate cyclase stimulation prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl rats. | PloS one 20110101 |
| Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells. | PloS one 20110101 |
| Overview of current therapeutic approaches for pulmonary hypertension. | Pulmonary circulation 20110101 |
| Lung transplantation for pulmonary hypertension. | Pulmonary circulation 20110101 |
| Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. | The European respiratory journal 20101001 |
| Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models. | Journal of hypertension 20100801 |
| [Pulmonary arterial hypertension--a rare form of pulmonary hypertension]. | Deutsche medizinische Wochenschrift (1946) 20100501 |
| Riociguat for pulmonary hypertension. | Future cardiology 20100301 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20100301 |
| Riociguat: an upcoming therapy in chronic thromboembolic pulmonary hypertension? | European respiratory review : an official journal of the European Respiratory Society 20100301 |
| Animal models related to congenital heart disease and clinical research in pulmonary hypertension. | Cardiology 20100101 |
| Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. | Journal of molecular medicine (Berlin, Germany) 20091101 |
| Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension. | Current opinion in investigational drugs (London, England : 2000) 20090901 |
| Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. | ChemMedChem 20090501 |
| First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension. | The European respiratory journal 20090401 |
| Molecule of the month. Riociguat. | Drug news & perspectives 20090401 |
| Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy. | European respiratory review : an official journal of the European Respiratory Society 20090301 |
| NO-independent, haem-dependent soluble guanylate cyclase stimulators. | Handbook of experimental pharmacology 20090101 |
| Pulmonary arterial hypertension: on the way to a manageable disease. | Current opinion in investigational drugs (London, England : 2000) 20080901 |
| NO-independent regulatory site on soluble guanylate cyclase. | Nature 20010308 |